Copied
 
 
2023, DKK
29.06.2024
Bruttoresultat

63.187'

Primær drift

256'

Årets resultat

-14.000

Aktiver

138''

Kortfristede aktiver

64.801'

Egenkapital

108''

Afkastningsgrad

0 %

Soliditetsgrad

78 %

Likviditetsgrad

224 %

Resultat
29.06.2024
Årsrapport
2023
29.06.2024
2022
20.07.2023
2021
04.07.2022
2020
06.07.2021
2019
20.07.2020
2018
01.05.2019
2017
11.04.2018
2016
17.05.2017
2015
12.05.2016
Nettoomsætning
Bruttoresultat63.187.00051.708.00056.768.00060.205.00065.396.00056.670.00046.245.000
Resultat af primær drift256.000-11.318.000-3.101.0007.926.00018.536.00014.086.0008.486.000
Indtægter af kapitalandele (tilknyttede og associerede) 0000000
Finansielle indtægter246.00036.0000369.000264.000269.000649.000
Finansieringsomkostninger-1.106.000-168.000-85.000-2.204.000-1.360.000-1.605.000-1.418.000
Andre finansielle omkostninger0000000
Resultat før skat143.000-11.784.000-1.948.0008.437.00017.669.00012.515.0006.553.000
Resultat-14.000-9.225.000-696.0007.186.00014.537.0009.708.0004.855.000
Forslag til udbytte00000-2.500.0000
Aktiver
29.06.2024
Årsrapport
2023
29.06.2024
2022
20.07.2023
2021
04.07.2022
2020
06.07.2021
2019
20.07.2020
2018
01.05.2019
2017
11.04.2018
2016
17.05.2017
2015
12.05.2016
Kortfristede varebeholdninger23.896.00034.193.00023.860.00019.133.00014.548.00015.181.00012.132.000
Kortfristede tilgodehavender fra salg og tjenesteydelser 39.210.00034.891.00032.133.00037.534.00034.962.00033.339.00025.314.000
Likvider1.695.0002.547.0003.732.00017.171.0006.153.000591.00066.000
Kortfristede aktiver64.801.00071.631.00059.725.00073.838.00055.663.00049.111.00037.512.000
Immaterielle aktiver og goodwill16.800.0005.511.0006.974.0009.412.0009.573.0009.464.0008.212.000
Finansielle anlægsaktiver01.301.0001.633.000365.000000
Materielle aktiver56.612.00063.977.00071.663.00062.225.00061.868.00059.640.00047.650.000
Langfristede aktiver73.412.00070.789.00080.270.00072.002.00071.441.00069.104.00055.862.000
Aktiver138.213.000142.420.000139.995.000145.840.000127.104.000118.215.00093.374.000
Aktiver
29.06.2024
Passiver
29.06.2024
Årsrapport
2023
29.06.2024
2022
20.07.2023
2021
04.07.2022
2020
06.07.2021
2019
20.07.2020
2018
01.05.2019
2017
11.04.2018
2016
17.05.2017
2015
12.05.2016
Forslag til udbytte000002.500.0000
Egenkapital107.977.000107.991.000117.214.000117.880.000110.981.00053.140.00043.432.000
Hensatte forpligtelser1.343.0001.186.0003.745.0004.997.0003.746.000862.0000
Langfristet gæld til banker0000000
Anden langfristet gæld002.600.0001.110.00000
Leverandører af varer og tjenesteydelser9.542.0007.983.00010.669.00011.386.0006.294.0007.877.00010.526.000
Kortfristede forpligtelser28.893.00033.243.00019.036.00020.363.00011.267.00033.639.00028.039.000
Gældsforpligtelser28.893.00033.243.00019.036.00022.963.00012.377.00064.213.00049.942.000
Forpligtelser28.893.00033.243.00019.036.00022.963.00012.377.00064.213.00049.942.000
Passiver138.213.000142.420.000139.995.000145.840.000127.104.000118.215.00093.374.000
Passiver
29.06.2024
Nøgletal
29.06.2024
Årsrapport
2023
29.06.2024
2022
20.07.2023
2021
04.07.2022
2020
06.07.2021
2019
20.07.2020
2018
01.05.2019
2017
11.04.2018
2016
17.05.2017
2015
12.05.2016
Afkastningsgrad 0,2 %-7,9 %-2,2 %5,4 %14,6 %11,9 %9,1 %
Dækningsgrad Na.Na.Na.Na.Na.Na.Na.
Resultatgrad Na.Na.Na.Na.Na.Na.Na.
Varelagerets omsætningshastighed Na.Na.Na.Na.Na.Na.Na.
Egenkapitals-forretning 0,0 %-8,5 %-0,6 %6,1 %13,1 %18,3 %11,2 %
Payout-ratio Na.Na.Na.Na.Na.25,8 %Na.
Gældsdæknings-nøgletal 23,1 %-6.736,9 %-3.648,2 %359,6 %1.362,9 %877,6 %598,4 %
Soliditestgrad 78,1 %75,8 %83,7 %80,8 %87,3 %45,0 %46,5 %
Likviditetsgrad 224,3 %215,5 %313,7 %362,6 %494,0 %146,0 %133,8 %
Resultat
29.06.2024
Gæld
29.06.2024
Årsrapport
29.06.2024
Nyeste:01.01.2023- 31.12.2023(offentliggjort: 29.06.2024)
Information om virksomhedens regnskabsklasse:The annual report for ADM Denmark A/S has been prepared in accordance with the Danish Financial Statements Act regulations for reporting class C enterprises (medium sized enterprises). The accounting policies are unchanged from last year, and the annual report is presented in DKK.
Beretning
29.06.2024
Dato for ledelsens godkendelse af årsrapporten:2024-06-28
Beskrivelse af usikkerhed ved indregning eller måling:Uncertainties in recognition or measurement Recognition and measurement in the Annual Report have not been subject to any uncertainty. Except the one stated in note 1
Beskrivelse af usædvanlige forhold, der kan have påvirket indregningen eller målingen:Unusual circumstances On the 24th May 2024, the management of the Company discovered that, in the years 2020 and 2021, the Company carried out self-financing without fulfilling the requirements established in Section 206 of the Danish Companies Act. The self-financing, not in compliance with the Danish Companies Act carries interest according to section 215 of such an act. The management of the Company adopted immediate actions to cure the situation. On the 21st of June, 2024 the board of directors of the Company approved to initiate recovery of the loan and notified ADM Hundested ApS a notice requesting repayment of the loan including interest calculated in accordance with section 215 of the Danish Companies Act. On the 24th of June, 2024, the Company received the repayment of the loan including interest for a total amount of 8. 967 t. kr.
Statement by Management on the annual report
Identifikation af den godkendte årsrapport:Today, the Board of Directors and the Managing Director have approved the annual report of ADM Denmark A/S for the financial year 1 January - 31 December 2023.
Management's review
Beskrivelse af virksomhedens væsentligste aktiviteter:Description of key activities of the company The Company's business is based on developing, manufacturing and marketing of probiotic produkt concepts for prevention and maintenance of people's overall health. The Company’s objective is to develop innovative and scientifically documented product solutions based on proprietary probiotics in combination with selected probiotic strains from third parties. It is The Company’s vision to be a global leading biotechnology company specialized in developing, producing and marketing turnkey probiotic product solutions as food supplements and OTC drugs.